The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Epigenetic Changes in Prostate Cancer: Implication for Diagnosis and Treatment
Abstract
Prostate cancer is the most common noncutaneous malignancy and the second leading cause of cancer death among men in the United States. DNA methylation and histone modifications are important epigenetic mechanisms of gene regulation and play essential roles both independently and cooperatively in tumor initiation and progression. Aberrant epigenetic events such as DNA hypo- and hypermethylation and altered histone acetylation have both been observed in prostate cancer, in which they affect a large number of genes. Although the list of aberrantly epigenetically regulated genes continues to grow, only a few genes have, so far, given promising results as potential tumor biomarkers for early diagnosis and risk assessment of prostate cancer. Thus, large-scale screening of aberrant epigenetic events such as DNA hypermethylation is needed to identify prostate cancer-specific epigenetic fingerprints. The reversibility of epigenetic aberrations has made them attractive targets for cancer treatment with modulators that demethylate DNA and inhibit histone deacetylases, leading to reactivation of silenced genes. More studies into the mechanism and consequence of demethylation are required before the cancer epigenome can be safely manipulated with therapeutics as a treatment modality. In this review, we examine the current literature on epigenetic changes in prostate cancer and discuss the clinical potential of cancer epigenetics for the diagnosis and treatment of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
CpG Islands in vertebrate genomes
Gardiner-Garden, M., & Frommer, M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90689-9 · Cited by 3,353
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,986
High sensitivity mapping of methylated cytosines
Susan, J. C., Harrison, J., Paul, C. L., & Frommer, M. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.15.2990 · Cited by 1,862
Cameron, E. E., Bachman, K. E., Myöhänen, S., Herman, J. G., & Baylin, S. B. (1999) · Nature Genetics · doi:10.1038/5047 · Cited by 1,857
Cellular differentiation, cytidine analogs and DNA methylation
Jones, P. A., & Taylor, S. M. (1980) · Cell · doi:10.1016/0092-8674(80)90237-8 · Cited by 1,831
Zhang, Y., & Reinberg, D. (2001) · Genes & Development · doi:10.1101/gad.927301 · Cited by 1,530
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9700 · Cited by 1,529
Induction of tumors in mice by genomic hypomethylation
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083558 · Cited by 1,499
In vivo amplification of the androgen receptor gene and progression of human prostate cancer
Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinänen, R., Palmberg, C., Palotie, A., Tammela, T., Isola, J., & Kallioniemi, O.-P. (1995) · Nature Genetics · doi:10.1038/ng0495-401 · Cited by 1,484
Human Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence
Lee, W.-H., Bookstein, R., Hong, F., Young, L.-J., Shew, J.-Y., & Lee, E. Y.-H. P. (1987) · Science · doi:10.1126/science.3823889 · Cited by 1,417
Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
Lehnertz, B., Ueda, Y., Derijck, A. A. H. A., Braunschweig, U., Perez-Burgos, L., Kubicek, S., Chen, T., Li, E., Jenuwein, T., & Peters, A. H. F. M. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00432-9 · Cited by 1,245
Epigenetics: Regulation Through Repression
Wolffe, A. P., & Matzke, M. A. (1999) · Science · doi:10.1126/science.286.5439.481 · Cited by 1,239
Felsenfeld, G., & Groudine, M. (2003) · Nature · doi:10.1038/nature01411 · Cited by 1,150
Fang, M., Wang, Y., Ai, N., Hou, Z., Sun, Y., Lu, H., Welsh, W. J., & Yang, C. S. (2003) · PubMed · Cited by 1,049
The Methyl-CpG-binding Protein MeCP2 Links DNA Methylation to Histone Methylation
Fuks, F., Hurd, P. J., Wolf, D., Nan, X., Bird, A. P., & Kouzarides, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210256200 · Cited by 994
Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., & Wolffe, A. P. (2000) · Nature Genetics · doi:10.1038/77124 · Cited by 942
Robertson, K. D., Uzvolgyi, E., Liang, G., Talmadge, C., Sumegi, J., Gonzales, F. A., & Jones, P. A. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.11.2291 · Cited by 853
Lee, W. H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W. S., Isaacs, W. B., & Nelson, W. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11733 · Cited by 838
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E., & Baylin, S. B. (1995) · PubMed · Cited by 796
Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression
Burbee, D. G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B., Randle, D., Kondo, M., Virmani, A., Bader, S., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.691 · Cited by 769
The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase
Fuks, F. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg332 · Cited by 760
DNA methylation, methyltransferases, and cancer
Robertson, K. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204341 · Cited by 736
Suppression of intestinal neoplasia by DNA hypomethylation
Laird, P. W., Jackson-Grusby, L., Fazeli, A., Dickinson, S. L., Edward Jung, W., Li, E., Weinberg, R. A., & Jaenisch, R. (1995) · Cell · doi:10.1016/0092-8674(95)90329-1 · Cited by 710
Veigl, M. L., Kasturi, L., Olechnowicz, J., Ma, A., Lutterbaugh, J. D., Periyasamy, S., Li, G.-M., Drummond, J., Modrich, P. L., Sedwick, W. D., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8698 · Cited by 648
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-210 · Cited by 627
Butler, L. M., Agus, D. B., Scher, H. I., Higgins, B., Rose, A., Cordon‐Cardo, C., Thaler, H. T., Rifkind, R. A., Marks, P. A., & Richon, V. M. (2000) · PubMed · Cited by 615
The Human Histone Deacetylase Family
Gray, S. G., & Ekström, T. J. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5080 · Cited by 546
Hypermethylation of CpG Islands in Primary and Metastatic Human Prostate Cancer
Yegnasubramanian, S., Kowalski, J., Gonzalgo, M. L., Zahurak, M., Piantadosi, S., Walsh, P. C., Bova, G. S., De Marzo, A. M., Isaacs, W. B., & Nelson, W. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3972 · Cited by 527
Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
Koh, J., Enders, G. H., David Dynlacht, B., & Harlow, E. (1995) · Nature · doi:10.1038/375506a0 · Cited by 516
Hypomethylation of ras oncogenes in primary human cancers
Feinberg, A. P., & Vogelstein, B. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(83)80115-6 · Cited by 514
DNA Mismatch Repair: Molecular Mechanisms and Biological Function
Schofield, M. J., & Hsieh, P. (2003) · Annual Review of Microbiology · doi:10.1146/annurev.micro.57.030502.090847 · Cited by 492
Strahl, B. D., Ohba, R., Cook, R. G., & Allis, C. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14967 · Cited by 491
Reduced genomic 5-methylcytosine content in human colonic neoplasia.
Feinberg, A. P., Gehrke, C. W., Kuo, K. C., & Ehrlich, M. (1988) · PubMed · Cited by 484
Dnmt3a binds deacetylases and is recruited by a sequence‐specific repressor to silence transcription
Fuks, F., Burgers, W. A., Godin, N., Kasai, M., & Kouzarides, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.10.2536 · Cited by 473
Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene.
Sakai, T., Toguchida, J., Ohtani, N., Yandell, D. W., Rapaport, J. M., & Dryja, T. P. (1991) · PubMed · Cited by 466
Androgen receptor gene mutations in human prostate cancer.
Newmark, J. R., Hardy, D. O., Tonb, D. C., Carter, B. S., Epstein, J. I., Isaacs, W. B., Brown, T. R., & Barrack, E. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6319 · Cited by 419
Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene
Bachman, K. E., Park, B. H., Rhee, I., Rajagopalan, H., Herman, J. G., Baylin, S. B., Kinzler, K. W., & Vogelstein, B. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00234-9 · Cited by 418
Lau, K., LaSpina, M., Long, J., & Ho, S. (2000) · PubMed · Cited by 407
Leav, I., Lau, K.-M., Adams, J. Y., McNeal, J. E., Taplin, M.-E., Wang, J., Singh, H., & Ho, S.-M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61676-8 · Cited by 394
Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma
Kawakami, K. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.22.1805 · Cited by 376
Maruyama, R., Toyooka, S., Toyooka, K. O., Virmani, A. K., Zöchbauer‐Müller, S., Farinas, A. J., Minna, J. D., McConnell, J. D., Frenkel, E. P., & Gazdar, A. F. (2002) · PubMed · Cited by 370
Critical Role of Histone Methylation in Tumor Suppressor Gene Silencing in Colorectal Cancer
Kondo, Y., Shen, L., & Issa, J.-P. J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.206-215.2003 · Cited by 346
Esteller, M., & Herman, J. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207316 · Cited by 326
The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC–Cdc20 complex
Song, M. S., Song, S. J., Ayad, N. G., Chang, J. S., Lee, J. H., Hong, H. K., Lee, H., Choi, N., Kim, J., Kim, H., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1091 · Cited by 311
Jeronimo, C., Usadel, H., Henrique, R., Oliveira, J., Lopes, C., Nelson, W. G., & Sidransky, D. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1747 · Cited by 306
Frequent loss of estrogen receptor-beta expression in prostate cancer.
Horvath, L. G., Henshall, S. M., Lee, C. S., Head, D. R., Quinn, D. I., Mäkelä, S., Delprado, W., Golovsky, D., Brenner, P. C., O’Neill, G., et al. (2001) · PubMed · Cited by 304
Goessl, C. D., Krause, H., Müller, M., Heicappell, R., Schrader, M. G., Sachsinger, J., & Miller, K. (2000) · PubMed · Cited by 304
Histone deacetylase inhibitors in cancer treatment
Vigushin, D. M., & Coombes, R. C. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200201000-00001 · Cited by 301
Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.
Cairns, P., Esteller, M., Herman, J. G., Schoenberg, M., Jerónimo, C., Sánchez‐Céspedes, M., Chow, N. ‐., Grasso, M., Wu, L. J., Westra, W. B., et al. (2001) · PubMed · Cited by 294
Expression of various genes is controlled by DNA methylation during mammalian development
Ehrlich, M. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10464 · Cited by 290
Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus
Lu, Q., Kaplan, M., Ray, D., Ray, D., Zacharek, S., Gutsch, D., & Richardson, B. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10234 · Cited by 286
DNA methyltransferase inhibitors—state of the art
Goffin, J., & Eisenhauer, E. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf314 · Cited by 283
CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.
Brooks, J. D., Weinstein, M. H., Lin, X., Sun, Y., Pin, S. S., Bova, G. S., Epstein, J. I., Isaacs, W. B., & Nelson, W. G. (1998) · PubMed · Cited by 282
Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors.
Stirzaker, C., Millar, D., Paul, C. L., Warnecke, P. M., Harrison, E. M., Vincent, P., Frommer, M., & Clark, S. J. (1997) · PubMed · Cited by 272
Stirzaker, C., Song, J. Z., Davidson, B., & Clark, S. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3690 · Cited by 240
HP1 Is Essential for DNA Methylation in Neurospora
Freitag, M., Hickey, P. C., Khlafallah, T. K., Read, N. D., & Selker, E. U. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00024-3 · Cited by 236
Zhuang, S.-H., & Burnstein, K. L. (1998) · Endocrinology · doi:10.1210/endo.139.3.5770 · Cited by 227
Richmond, P. J. M., Karayiannakis, A. J., Nagafuchi, A., Kaisary, A. V., & Pignatelli, M. N. (1997) · PubMed · Cited by 226
CpG islands as genomic footprints of promoters that are associated with replication origins
Antequera, F., & Bird, A. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80418-7 · Cited by 224
Hypomethylation of DNA in pathological conditions of the human prostate.
Bedford, M. T., & van Helden, P. D. (1987) · PubMed · Cited by 219
Lee, W. H., Isaacs, W. B., Bova, G. S., & Nelson, W. G. (1997) · PubMed · Cited by 217
Otterson, G. A., Khleif, S. N., Chen, W., Coxon, A. B., & Kaye, F. J. (1995) · PubMed · Cited by 212
Camphausen, K., Burgan, W., Cerra, M., Oswald, K. A., Trepel, J. B., Lee, M.-J., & Tofilon, P. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2630 · Cited by 209
Mutagenicity of 5-aza-2′-deoxycytidine is mediated by the mammalian DNA methyltransferase
Jackson-Grusby, L., Laird, P. W., Magge, S. N., Moeller, B. J., & Jaenisch, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4681 · Cited by 208
Baylin, S. B., Makos, M., Wu, J. J., Yen, R. W. C., de Bustros, A., Vertino, P. M., & Nelkin, B. D. (1991) · PubMed · Cited by 206
Segura-Pacheco, B. A., Trejo‐Becerril, C., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Mariscal, I., Chavez, A., Acuña, C., Salazar, A. M., Lizano, M., & Dueñas‐González, A. (2003) · PubMed · Cited by 206
Zhu, X., Leav, I., Leung, Y.-K., Wu, M., Liu, Q., Gao, Y., McNeal, J. E., & Ho, S.-M. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63760-1 · Cited by 205
Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer
Jernimo, C., Usadel, H., Henrique, R., Silva, C., Oliveira, J., Lopes, C., & Sidransky, D. (2002) · Urology · doi:10.1016/s0090-4295(02)01949-0 · Cited by 201
Methylation and Inactivation of Estrogen, Progesterone, and Androgen Receptors in Prostate Cancer
Sasaki, M. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.5.384 · Cited by 198
Kinoshita, H., Shi, Y., Sandefur, C., Meisner, L. F., Chang, C., Choon, A., Reznikoff, C., Bova, G. S., Friedl, A., & Jarrard, D. F. (2000) · PubMed · Cited by 194
Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.
Gonzalgo, M. L., Pavlovich, C. P., Lee, S. M., & Nelson, W. G. (2003) · PubMed · Cited by 192
Cote, R. J., Shi, Y., Groshen, S. G., Feng, A., Skinner, D. G., Lieskovosky, G., & Cordon‐Cardo, C. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.916 · Cited by 191
Soares, J., Pinto, A. E., Cunha, C. V., Andr�, S., Bar�o, I., Sousa, J. M., & Cravo, M. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990101)85:1<112::aid-cncr16>3.0.co;2-t · Cited by 187
Murphy, G. P., Tjoa, B. A., Simmons, S. J., Ragde, H., Rogers, M., Elgamal, A., Kenny, G. M., Troychak, M. J., Salgaller, M. L., & Boynton, A. L. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990401)39:1<8::aid-pros2>3.0.co;2-n · Cited by 185
Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma
Greger, V., Debus, N., Lohmann, D., H�pping, W., Passarge, E., & Horsthemke, B. (1994) · Human Genetics · doi:10.1007/bf00211013 · Cited by 184
High frequency of alterations in DNA methylation in adenocarcinoma of the prostate
Santourlidis, S., Florl, A., Ackermann, R., Wirtz, H.-C., & Schulz, W. A. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990515)39:3<166::aid-pros4>3.0.co;2-j · Cited by 184
The Relationship between Hypomethylation and CpG Island Methylation in Colorectal Neoplasia
Bariol, C., Suter, C., Cheong, K., Ku, S.-L., Meagher, A., Hawkins, N., & Ward, R. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63932-6 · Cited by 183
Lin, X., Asgari, K., PUTZI, M. J., Gage, W. R., Yu, X., Cornblatt, B. S., Kumar, A., Piantadosi, S., DeWeese, T. L., Marzo, A. M. D., et al. (2001) · PubMed · Cited by 180
Jarrard, D. F., Bova, G. S., Ewing, C. M., Pin, S. S., Nguyen, S. H., Baylin, S. B., Cairns, P., Sidransky, D., Herman, J. G., & Isaacs, W. B. (1997) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199706)19:2<90::aid-gcc4>3.0.co;2-v · Cited by 175
Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma
Schulz, W. A., Elo, J. P., Florl, A. R., Pennanen, S., Santourlidis, S., Engers, R., Buchardt, M., Seifert, H., & Visakorpi, T. (2002) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10092 · Cited by 165
Yang, E. S.-H., & Burnstein, K. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306340200 · Cited by 162
Weiser, T. S., Guo, Z. S., Ohnmacht, G. A., Parkhurst, M. L., Tong-On, P., Marincola, F. M., Fischette, M. R., Yu, X., Chen, G. A., Hong, J. A., et al. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200103000-00010 · Cited by 162
Ghoshal, K., Datta, J., Majumder, S., Bai, S., Dong, X. C., Parthun, M. R., & Jacob, S. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.23.8302-8319.2002 · Cited by 159
Kuzmin, I., Gillespie, J. W., Protopopov, A. I., Geil, L., Dreijerink, K. M. A., Yang, Y., Vocke, C. D., Duh, F.-M. C., Zabarovsky, E. R., Minna, J. D., et al. (2002) · PubMed · Cited by 158
Hypomethylation: One Side of a Larger Picture
DUNN, B. K. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05960.x · Cited by 158
DNA-based detection of prostate cancer in urine after prostatic massage
Goessl, C. D., Müller, M., Heicappell, R., Krause, H., Straub, B., Schrader, M. G., & Miller, K. (2001) · Urology · doi:10.1016/s0090-4295(01)01268-7 · Cited by 158
Epigenetic Regulation of Androgen Receptor Gene Expression in Human Prostate Cancers
Nakayama, T., Watanabe, M., Suzuki, H., Toyota, M., Sekita, N., HIROKAWA, Y. S., Mizokami, A., Itô, H., Yatani, R., & Shiraishi, T. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780190 · Cited by 154
Kuefer, R., Hofer, M. D., Altug, V., Zorn, C. S., Genze, F., Kunzi‐Rapp, K., Hautmann, R. E., & Gschwend, J. E. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601510 · Cited by 152
Brolin, J., Ekman, P., & Skoog, L. K. (1992) · The Prostate · doi:10.1002/pros.2990200404 · Cited by 150
Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression.
Li, L. C., Chui, R. M., Nakajima, K., Oh, B. R., Au, H. C., & Dahiya, R. (2000) · PubMed · Cited by 150
Self-citationHarden, S., Guo, Z., Epstein, J. I., & Sidransky, D. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000049627.90307.4d · Cited by 148
Androgen receptor status of lymph node metastases from prostate cancer
Hobisch, A., Čulig, Z., Radmayr, C., Bartsch, G., Klocker, H., & Hittmair, A. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(199602)28:2<129::aid-pros9>3.0.co;2-b · Cited by 147
Nelson, J. B., Lee, W. H., Nguyen, S. H., Jarrard, D. F., Brooks, J. D., Magnuson, S. R., Opgenorth, T. J., Nelson, W. G., & Bova, G. S. (1997) · PubMed · Cited by 143
Kaneda, A., Tsukamoto, T., Takamura‐Enya, T., Watanabe, N., Kaminishi, M., Sügimura, T., Tatematsu, M., & Ushijima, T. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03171.x · Cited by 143
Methylation of the CD44 metastasis suppressor gene in human prostate cancer.
Lou, W., Krill, D., Dhir, R., Becich, M. J., Dong, J., Frierson, H. F., Isaacs, W. B., Isaacs, J. T., & Gao, A. C. (1999) · PubMed · Cited by 142
Cho, B., Lee, H., Jeong, S., Bang, Y., Lee, H. J., Hwang, K. S., Kim, H., Lee, Y., Kang, G. H., & Jeoung, D. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01121-5 · Cited by 142
Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients.
Battagli, C., Uzzo, R. G., Dulaimi, E., de Cáceres, I. I., Krassenstein, R., Al‐Saleem, T., Greenberg, R. E., & Cairns, P. (2003) · PubMed · Cited by 142
Thibault, A., Figg, W. D., Bergan, R. C., Lush, R. M., Myers, C. E., Tompkins, A. C., Reed, E., & Samid, D. (1998) · Tumori Journal · doi:10.1177/030089169808400120 · Cited by 140
Procainamide inhibits DNA methyltransferase in a human T cell line.
Scheinbart, L., Johnson, M. A., Gross, L. A., Edelstein, S., & Richardson, B. C. (1991) · PubMed · Cited by 139
Aberrant Methylation of Gene Promoters in Cancer--Concepts, Misconcepts, and Promise
Baylin, S. B. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1460 · Cited by 137
Epigenetic Regulation of a Novel Tumor Suppressor Gene (hDAB2IP) in Prostate Cancer Cell Lines
Chen, H., Toyooka, S., Gazdar, A. F., & Hsieh, J. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208230200 · Cited by 135
Nakayama, T., Watanabe, M., Yamanaka, M., HIROKAWA, Y. S., Suzuki, H., Itô, H., Yatani, R., & Shiraishi, T. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780316 · Cited by 132
Pi-class glutathione S-transferase: regulation and function
Henderson, C. J., McLaren, A. W., Moffat, G. J., Bacon, E. J., & Wolf, C. R. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00176-2 · Cited by 129
Singal, R., van Wert, J., & Bashambu, M. (2001) · PubMed · Cited by 129
Identification and Characterization of a Novel Cancer/Testis Antigen Gene CAGE
Cho, B., Lim, Y., Lee, D.-Y., Park, S., Lee, H., Kim, W. H., Yang, H.-K., Bang, Y., & Jeoung, D. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6701 · Cited by 127
Quantitative GSTP1 Methylation and the Detection of Prostate Adenocarcinoma in Sextant Biopsies
Harden, S. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg082 · Cited by 127
Androgen receptor expression in androgen‐independent prostate cancer cell lines
Chlenski, A., Nakashiro, K., Ketels, K. V., Коровайцева, Г. И., & Oyasu, R. (2001) · The Prostate · doi:10.1002/pros.1048 · Cited by 126
METHYLATION OF THE E-CADHERIN GENE PROMOTER CORRELATES WITH PROGRESSION OF PROSTATE CANCER
Li, L., ZHAO, H., Nakajima, K., Oh, B. R., Ribeiro‐Filho, L. A., Carroll, P. R., & Dahiya, R. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)66047-8 · Cited by 125
Self-citationButler, L. M., Webb, Y., Agus, D. B., Higgins, B., Tolentino, T., Kutko, M. C., LaQuaglia, M. P., Drobnjak, M., Cordon‐Cardo, C., Scher, H. I., et al. (2001) · PubMed · Cited by 120
Inhibitors of histone deacetylase are potentially effective anticancer agents.
Marks, P. A., Rifkind, R. A., Richon, V. M., & Breslow, R. (2001) · PubMed · Cited by 119
Rashid, S. F., Moore, J. S., Walker, E. S., Driver, P. M., Engel, J., Edwards, C. E., Brown, G., Uskoković, M. R., & Campbell, M. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204269 · Cited by 119
Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma.
Cravo, M. L., Pinto, R., Fidalgo, P., Chaves, P. P., Glória, L., Nobre-Leitao, C. A., & Mira, F. C. (1996) · Gut · doi:10.1136/gut.39.3.434 · Cited by 118
Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation.
Padar, A., Sathyanarayana, U. G., Suzuki, M., Maruyama, R., Hsieh, J., Frenkel, E. P., Minna, J. D., & Gazdar, A. F. (2003) · PubMed · Cited by 117
Cloning and Characterization of Human Estrogen Receptor β Promoter
Li, L., Yeh, C., Nojima, D., & Dahiya, R. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3363 · Cited by 116
Self-citationHuang, H., Reed, C. P., Zhang, J. S., Shridhar, V., Wang, L., & Smith, D. I. (1999) · PubMed · Cited by 110
Kallakury, B., Sheehan, C. E., Winn-Deen, E. S., Oliver, J., Fisher, H. A. �., Kaufman, R. P., & Ross, J. S. (2001) · Cancer · doi:10.1002/1097-0142(20011201)92:11<2786::aid-cncr10128>3.0.co;2-i · Cited by 109
Moffatt, K. A., Johannes, W. U., & Miller, G. J. (1999) · PubMed · Cited by 108
Milutinovic, S., Brown, S. E., Zhuang, Q., & Szyf, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312823200 · Cited by 103
Two principles in endocrine therapy of cancers: hormone deprival and hormone interference.
Huggins, C. (1964) · PubMed · Cited by 101
Tsujiuchi, T., Tsutsumi, M., Sasaki, Y., Takahama, M., & Konishi, Y. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00834.x · Cited by 101
Yao, X., Hu, J., Daniels, M., Shiran, H., Zhou, X., Yan, H., Lü, H., Zeng, Z., Wang, Q., Li, T., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15109 · Cited by 101
Retinoblastoma gene mutations in primary human prostate cancer
Kubota, Y., Fujinami, K., Uemura, H., Dobashi, Y., Miyamoto, H., Iwasaki, Y., Kitamura, H., & Shuin, T. (1995) · The Prostate · doi:10.1002/pros.2990270604 · Cited by 98
Heterogeneous Methylation and Deletion Patterns of the INK4a/ARF Locus Within Prostate Carcinomas
Konishi, N., Nakamura, M., Kishi, M., Nishimine, M., Ishida, E., & Shimada, K. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62547-3 · Cited by 94
Pakneshan, P., Xing, R. H., & Rabbani, S. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0973com · Cited by 94
Inhibition of promoter activity by methylation: possible involvement of protein mediators.
Levine, A., Cantoni, G. L., & Razin, A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6515 · Cited by 86
Suenaga, M., Soda, H., Oka, M., Yamaguchi, A., Nakatomi, K., Shiozawa, K., Kawabata, S., Kasai, T., Yamada, Y., Kamihira, S., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.10082 · Cited by 81
Zhang, J., Liu, L., & Pfeifer, G. P. (2003) · Oncogene · doi:10.1038/sj.onc.1207328 · Cited by 80
Sasakawa, Y., Naoe, Y., Noto, T., Inoue, T., Sasakawa, T., Matsuo, M., Manda, T., & Mutoh, S. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00411-8 · Cited by 79
Developing Molecular Biomarkers for Cancer
Ransohoff, D. F. (2003) · Science · doi:10.1126/science.1083158 · Cited by 78
Nojima, D., Li, L.-C., Dharia, A., PERINCHERY, G., Ribeiro‐Filho, L. A., YEN, T.-S., & Dahiya, R. (2001) · Cancer · Cited by 78
Self-citationThelen, P., Schweyer, S., Hemmerlein, B., Wuttke, W., Seseke, F., & Ringert, R.-H. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.1.25 · Cited by 71
Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis
Gonzalgo, M. L., Nakayama, M., Lee, S. M., Marzo, A. M. D., & Nelson, W. G. (2004) · Urology · doi:10.1016/j.urology.2003.08.039 · Cited by 71
Amplification of urokinase gene in prostate cancer.
Helenius, M. A., Saramäki, O. R., Linja, M. J., Tammela, T. L. J., & Visakorpi, T. (2001) · PubMed · Cited by 70
Pong, R.-C., Lai, Y.-J., Chen, H., Okegawa, T., Frenkel, E. P., Sagalowsky, A. I., & Hsieh, J. (2003) · PubMed · Cited by 68
Frühwald, M. C., & Plass, C. (2002) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3265 · Cited by 67
DNA Hypermethylation Status of Multiple Genes in Prostate Adenocarcinomas
Konishi, N., Nakamura, M., Kishi, M., Nishimine, M., Ishida, E., & Shimada, K. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01318.x · Cited by 66
Cormier, R. T., & Dove, W. F. (2000) · PubMed · Cited by 64
Aberrant methylation of genes in low-grade astrocytomas
Costello, J., Plass, C., & Cavenee, W. K. (2000) · Brain Tumor Pathology · doi:10.1007/bf02482735 · Cited by 61
Goldsmith, M. E., Kitazono, M., Fok, P. T., Aikou, T., Bates, S. E., & Fojo, T. (2003) · PubMed · Cited by 61
Prostate phenotypes in estrogen-modulated transgenic mice
Jarred, R. A., McPherson, S. J., Bianco, J. J., Couse, J. F., Korach, K. S., & Risbridger, G. P. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00575-1 · Cited by 60
Urokinase-Type Plasminogen Activator Expression in Human Prostate Carcinomas
Veldhuizen, P. J. V., Sadasivan, R., Cherian, R., & Wyatt, A. (1996) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)41739-2 · Cited by 60
Silencing of CD44 Expression in Prostate Cancer by Hypermethylation of the CD44 Promoter Region
Verkaik, N. S., van Steenbrugge, G. J., van Weerden, W. M., Bussemakers, M. J. G., & van der Kwast, T. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780137 · Cited by 57
Endothelin B receptor gene hypermethylation in prostate adenocarcinoma: Figure 1
Jerónimo, C., Henrique, R., Campos, P. F., Oliveira, J., Caballero, O. L., Lopes, C., & Sidransky, D. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.56.1.52 · Cited by 57
PGDB: a curated and integrated database of genes related to the prostate
Li, L.-C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg008 · Cited by 55
Self-citationVerkaik, N. S., Trapman, J., Romijn, J. C., van der Kwast, T., & van Steenbrugge, G. J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990129)80:3<439::aid-ijc17>3.0.co;2-v · Cited by 54
Cell cycle regulators and their abnormalities in breast cancer
Fernández, P. L., Jares, P., Rey, M. J., Campo, E., & Cardesa, A. (1998) · Molecular Pathology · doi:10.1136/mp.51.6.305 · Cited by 52
Ikeda, N., Uemura, H., Ishiguro, H., Hori, M., Hosaka, M., Kyo, S., Miyamoto, K., Takeda, E., & Kubota, Y. (2003) · PubMed · Cited by 52
Methylation and the Genome: the Power of a Small Amendment
Urnov, F. D. (2002) · Journal of Nutrition · doi:10.1093/jn/132.8.2450s · Cited by 49
Christoph Lengauer, C. (2003) · Science · doi:10.1126/science.1084468 · Cited by 46
Analysis of the p16 tumor suppressor gene in early‐stage prostate cancer
Gu, K., Mes‐Masson, A., Gauthier, J. B., & Saad, F. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199803)21:3<164::aid-mc3>3.3.co;2-c · Cited by 45
Sasakawa, Y., Naoe, Y., Inoue, T., Sasakawa, T., Matsuo, M., Manda, T., & Mutoh, S. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00184-8 · Cited by 43
Differential Activation of the IGF Binding Protein-3 Promoter by Butyrate in Prostate Cancer Cells
Tsubaki, J., Hwa, V., Twigg, S. M., & Rosenfeld, R. G. (2002) · Endocrinology · doi:10.1210/endo.143.5.8766 · Cited by 43
Dynamic methylation of histone H3 at lysine 4 in transcriptional regulation by the androgen receptor
Kim, J. P., Jia, L., Tilley, W. D., & Coetzee, G. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg909 · Cited by 43
Izbicka, E., MacDonald, J. R., Davidson, K. K., et al. (1999) · PubMed · Cited by 42
Acetylation and Methylation in Nuclear Receptor Gene Activation
Xu, W., Cho, H. K., & Evans, R. M. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)64012-7 · Cited by 40
Hypermethylation of the Inhibin α-Subunit Gene in Prostate Carcinoma
Schmitt, J. F., Millar, D., Pedersen, J. S., Clark, S. L., Venter, D. J., Frydenberg, M., Molloy, P. L., & Risbridger, G. P. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.2.0771 · Cited by 38
Nonhormonal mechanism of sexual inadequacy in patients with varicocele
Nahoum, C. R. D., & Freire, F. (1985) · Urology · doi:10.1016/0090-4295(85)90563-1 · Cited by 22
Vis, A. N., Oomen, M. H., Schröder, F. H., & van der Kwast, T. (2001) · Molecular Urology · doi:10.1089/10915360152745894 · Cited by 13
Cited by
Molecular genetics of prostate cancer: new prospects for old challenges
Shen, M. M., & Abate-Shen, C. (2010) · Genes & Development · doi:10.1101/gad.1965810 · Cited by 946
Discovery and development of SAHA as an anticancer agent
Marks, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210204 · Cited by 626
Weichert, W., Röske, A., Gekeler, V, Beckers, T., Stephan, C., Jung, K., Fritzsche, F. R., Niesporek, S., Denkert, C., Dietel, M., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604199 · Cited by 477
Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer
Kim, J. H., Dhanasekaran, S. M., Prensner, J. R., Cao, X., Robinson, D., Kalyana-Sundaram, S., Huang, C., Shankar, S., Jing, X., Iyer, M., et al. (2011) · Genome Research · doi:10.1101/gr.119347.110 · Cited by 188
Mogal, A., & Abdulkadir, S. A. (2006) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2005.09.008 · Cited by 67
Metadata
- Authors
- Li, L.-C., Carroll, P. R., & Dahiya, R.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-01-19
- Volume
- 97
- Issue
- 2
- Pages
- 103-115
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2133918562
- Cited by
- 299
- References
- 166
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.